Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.

Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored.

You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/

 

Highlights this week included:

US: Classen v Biogen (not precedential): Federal Circuit applies Bilski to the life sciences (Holman’s Biotech IP Blog) (Inventive Step) (Hal Wegner) (EFF) (Patently-O) (Patent Prospector) (The Fire of Genius) (Patent Baristas) (Managing Intellectual Property) (Patent Docs) (Spicy IP)

 

General

India: Investing farmers with IP rights through plant varieties protection (International Law Office)

Kenya: End of the road for Anti-Counterfeit Bill (Afro-IP)

Switzerland: New Patent Act – biotechnological inventions (International Law Office)

US: Classen v Biogen (not precedential): Federal Circuit applies Bilski to the life sciences (Holman’s Biotech IP Blog) (Inventive Step) (Hal Wegner) (EFF) (Patently-O) (Patent Prospector) (The Fire of Genius) (Patent Baristas) (Managing Intellectual Property) (Patent Docs) (Spicy IP)

 

Products

Clarinex (Desloratadine) – US: Dr Reddy’s settles Clarinex patent infringement lawsuits with Sepracor and Schering-Plough (Patent Circle) (GenericsWeb)

Doryx (Doxycycline) – US: Warner Chilcott, Mayne Pharma file lawsuits against Mutual Pharmaceutical, Mylan and Impax for infringement of Doryx patent (SmartBrief)

Femcon (Norethindrone, Ethinyl estradiol) – US: Warner Chilcott and Barr announce settlement of Femcon patent challenge (SmartBrief)

OxyContin (Oxycodone) – UK: EWHC Patents Court rules Oxycodone patents valid but not infringed: ratiopharm & Sandoz v Napp Pharmaceuticals (IPKat)

Plavix (Clopidogrel) – US: CAFC upholds Plavix patent: Sanofi-Synthelabo v. Apotex, Inc (Managing Intellectual Property)